TXA for GI Bleeds? The HALT-IT Trial

July 15, 2020 00:26:28
TXA for GI Bleeds?  The HALT-IT Trial
Critical Care Perspectives in Emergency Medicine
TXA for GI Bleeds? The HALT-IT Trial

Jul 15 2020 | 00:26:28

/

Show Notes

The use of tranexamic acid (TXA) has markedly increased since the results of the CRASH-II trial were published.  In addition to its use in trauma, TXA has been evaluated and used in numerous other conditions, including post-partum hemorrhage and epistaxis.  Recently, the HALT-IT Trial was published online in the Lancet, which evaluated the use of TXA in patients with acute gastrointestinal bleeding.  In this podcast we discuss the HALT-IT Trial and its implications for clinical practice. 

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

November 25, 2018 00:22:59
Episode Cover

The Post-Cardiac Surgery Patient in Your ED!

More than 200,000 patients per year undergo coronary artery bypass graft (CABG) surgery. Up to 20 percent of these patients will require readmission within...

Listen

Episode 0

August 12, 2018 00:28:22
Episode Cover

Updates in Acute Ischemic Stroke

Neurocritical Care guru Dr. Evie Marcolini is back to review recent literature and practice changes in the management of patients with acute ischemic stroke. ...

Listen

Episode 0

February 16, 2021 00:19:11
Episode Cover

The HOT-ICU Study

Critically ill patients with acute hypoxic respiratory failure receive supplemental oxygen as a component of their treatment.  In recent years, exposure to high levels...

Listen